287 related articles for article (PubMed ID: 9618763)
1. X-linked agammaglobulinemia: lack of mature B lineage cells caused by mutations in the Btk kinase.
Smith CI; Bäckesjö CM; Berglöf A; Brandén LJ; Islam T; Mattsson PT; Mohamed AJ; Müller S; Nore B; Vihinen M
Springer Semin Immunopathol; 1998; 19(4):369-81. PubMed ID: 9618763
[No Abstract] [Full Text] [Related]
2. X-linked agammaglobulinemia. A clinical and molecular analysis.
Ochs HD; Smith CI
Medicine (Baltimore); 1996 Nov; 75(6):287-99. PubMed ID: 8982147
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
[TBL] [Abstract][Full Text] [Related]
4. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
Tsukada S; Witte ON
Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
[No Abstract] [Full Text] [Related]
5. Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia.
Brunner C; Kreth HW; Ochs HD; Schuster V
J Clin Immunol; 2002 Jul; 22(4):244-51. PubMed ID: 12148599
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of mutations in Btk that cause X-linked agammaglobulinemia.
Conley ME; Rohrer J
Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S192-7. PubMed ID: 7554467
[No Abstract] [Full Text] [Related]
7. Atypical X-linked agammaglobulinemia diagnosed in three adults.
Hashimoto S; Miyawaki T; Futatani T; Kanegane H; Usui K; Nukiwa T; Namiuchi S; Matsushita M; Yamadori T; Suemura M; Kishimoto T; Tsukada S
Intern Med; 1999 Sep; 38(9):722-5. PubMed ID: 10480303
[TBL] [Abstract][Full Text] [Related]
8. Hypogammaglobulinemia: fifty years later.
Conley ME
Clin Immunol; 2002 Sep; 104(3):201-3. PubMed ID: 12217328
[No Abstract] [Full Text] [Related]
9. Sustained correction of B-cell development and function in a murine model of X-linked agammaglobulinemia (XLA) using retroviral-mediated gene transfer.
Yu PW; Tabuchi RS; Kato RM; Astrakhan A; Humblet-Baron S; Kipp K; Chae K; Ellmeier W; Witte ON; Rawlings DJ
Blood; 2004 Sep; 104(5):1281-90. PubMed ID: 15142874
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of Bruton's tyrosine kinase domain suggests a novel pathway for activation and provides insights into the molecular basis of X-linked agammaglobulinemia.
Mao C; Zhou M; Uckun FM
J Biol Chem; 2001 Nov; 276(44):41435-43. PubMed ID: 11527964
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Btk mutations in patients with X-linked agammaglobulinaemia (XLA) and determination of carrier status in normal female relatives: a nationwide study of Btk deficiency in Greece.
Speletas M; Kanariou M; Kanakoudi-Tsakalidou F; Papadopoulou-Alataki E; Arvanitidis K; Pardali E; Constantopoulos A; Kartalis G; Vihinen M; Sideras P; Ritis K
Scand J Immunol; 2001 Sep; 54(3):321-7. PubMed ID: 11555397
[TBL] [Abstract][Full Text] [Related]
12. X-linked agammaglobulinemia: new approaches to old questions based on the identification of the defective gene.
Conley ME; Parolini O; Rohrer J; Campana D
Immunol Rev; 1994 Apr; 138():5-21. PubMed ID: 8070817
[TBL] [Abstract][Full Text] [Related]
13. Maternal germinal mosaicism of X-linked agammaglobulinemia.
Sakamoto M; Kanegane H; Fujii H; Tsukada S; Miyawaki T; Shinomiya N
Am J Med Genet; 2001 Mar; 99(3):234-7. PubMed ID: 11241495
[TBL] [Abstract][Full Text] [Related]
14. Role of Bruton's tyrosine kinase in immunodeficiency.
Tsukada S; Rawlings DJ; Witte ON
Curr Opin Immunol; 1994 Aug; 6(4):623-30. PubMed ID: 7946052
[TBL] [Abstract][Full Text] [Related]
15. Point mutation in intron 11 of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.
Shinomiya N; Kanegane H; Watanabe A; Yamaguchi Y; Futatani T; Miyawaki T
Pediatr Int; 2000 Dec; 42(6):689-92. PubMed ID: 11192530
[No Abstract] [Full Text] [Related]
16. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the diagnosis of X-linked agammaglobulinemia.
Nonoyama S
Intern Med; 1999 Sep; 38(9):687-8. PubMed ID: 10480296
[No Abstract] [Full Text] [Related]
18. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
[TBL] [Abstract][Full Text] [Related]
19. X-linked agammaglobulinemia and other immunoglobulin deficiencies.
Smith CI; Islam KB; Vorechovský I; Olerup O; Wallin E; Rabbani H; Baskin B; Hammarström L
Immunol Rev; 1994 Apr; 138():159-83. PubMed ID: 8070814
[No Abstract] [Full Text] [Related]
20. BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations.
Tao L; Boyd M; Gonye G; Malone B; Schwaber J
Hum Mutat; 2000 Dec; 16(6):528-9. PubMed ID: 11102984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
